Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Sale of 568 CBIO shares, $10.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale | 568 | $10.2K |
| Jun 23, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale | 1,112 | $20.0K |
| Dec 17, 2025 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 14,422 | n/a |
| Mar 13, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 1,343 | $15.3K |
| Mar 7, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 917 | $10.8K |
| Feb 18, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,488 | $34.7K |
| Dec 12, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 1,455 | $40.9K |
| Dec 6, 2024 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 32,700 | n/a |
| Nov 18, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,735 | $77.1K |
| Sep 19, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 1,390 | $48.0K |